📊 AEHR Key Takeaways
Is Aehr Test Systems (AEHR) a Good Investment?
AEHR exhibits severe operational distress with negative operating margins of -41.8% and negative free cash flow of -3.3M despite modest revenue of $20.9M. The company is burning cash operationally while making capital investments, indicating fundamental business model challenges that are not being offset by scale or efficiency improvements. While the balance sheet remains fortress-like with minimal debt and $30.8M in cash, the persistent unprofitability and negative cash generation trajectory pose existential risks if operational losses continue.
Aehr Test Systems shows weak current fundamentals, with flat revenue, deeply negative operating and net margins, and negative free cash flow. The balance sheet is a major offset, with substantial cash, no long-term debt, and very strong liquidity, but the core issue is that profitability and cash generation have deteriorated despite a well-capitalized position. Until revenue growth resumes and margins recover, the business looks fundamentally pressured rather than attractive.
Why Buy Aehr Test Systems Stock? AEHR Key Strengths
- Fortress balance sheet with $30.8M cash and zero long-term debt providing 13+ months of runway at current burn rate
- Exceptional liquidity position with current ratio of 10.62x enabling financial flexibility
- Maintained moderate gross margin of 30% indicating product pricing power despite operational challenges
- Debt-free balance sheet with $30.84M in cash and no long-term debt
- Very strong liquidity profile with a 10.62x current ratio and 5.47x quick ratio
- Large equity base and low liabilities provide resilience during operating weakness
AEHR Stock Risks: Aehr Test Systems Investment Risks
- Severe profitability crisis with negative operating margin of -41.8% and net loss of -$5.3M indicating structural business model problems
- Negative free cash flow of -$3.3M despite near-zero revenue growth suggesting operational efficiency is deteriorating rather than improving
- EPS deterioration of -111.6% YoY and sustained losses indicate company is in distressed state rather than temporary downturn phase
- High insider trading activity (30 Form 4 filings in 90 days) may signal uncertainty or opportunistic equity liquidation
- Operating performance is weak, with a -41.8% operating margin and -25.5% net margin
- Revenue growth is stalled, suggesting poor absorption of costs and limited near-term momentum
- Negative operating cash flow and negative free cash flow indicate weak earnings quality and cash conversion
Key Metrics to Watch
- Operating cash flow trajectory and path to positive FCF generation
- Revenue growth acceleration and corresponding operating leverage improvements
- Operating margin recovery toward break-even and positive territory
- Cash burn rate and remaining runway before liquidity crisis
- Revenue growth and gross margin recovery
- Operating cash flow and free cash flow trend
Aehr Test Systems (AEHR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 10.62x current ratio provides a solid financial cushion.
AEHR Profit Margin, ROE & Profitability Analysis
AEHR vs Utilities Sector: How Aehr Test Systems Compares
How Aehr Test Systems compares to Utilities sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Aehr Test Systems Stock Overvalued? AEHR Valuation Analysis 2026
Based on fundamental analysis, Aehr Test Systems has mixed fundamental signals relative to the Utilities sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Aehr Test Systems Balance Sheet: AEHR Debt, Cash & Liquidity
AEHR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Aehr Test Systems's revenue has grown significantly by 197% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.50 reflects profitable operations.
AEHR Revenue Growth, EPS Growth & YoY Performance
AEHR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $10.3M | -$643.0K | $-0.02 |
| Q2 2026 | $9.9M | -$368.0K | $-0.01 |
| Q1 2026 | $11.0M | $660.0K | $0.02 |
| Q3 2025 | $7.6M | -$643.0K | $-0.02 |
| Q2 2025 | $13.5M | -$368.0K | $-0.01 |
| Q1 2025 | $13.1M | $660.0K | $0.02 |
| Q3 2024 | $7.6M | -$1.5M | $-0.05 |
| Q2 2024 | $14.8M | $3.7M | $0.13 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Aehr Test Systems Dividends, Buybacks & Capital Allocation
AEHR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Aehr Test Systems (CIK: 0001040470)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AEHR
What is the AI rating for AEHR?
Aehr Test Systems (AEHR) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (SELL) with 82% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AEHR's key strengths?
Claude: Fortress balance sheet with $30.8M cash and zero long-term debt providing 13+ months of runway at current burn rate. Exceptional liquidity position with current ratio of 10.62x enabling financial flexibility. ChatGPT: Debt-free balance sheet with $30.84M in cash and no long-term debt. Very strong liquidity profile with a 10.62x current ratio and 5.47x quick ratio.
What are the risks of investing in AEHR?
Claude: Severe profitability crisis with negative operating margin of -41.8% and net loss of -$5.3M indicating structural business model problems. Negative free cash flow of -$3.3M despite near-zero revenue growth suggesting operational efficiency is deteriorating rather than improving. ChatGPT: Operating performance is weak, with a -41.8% operating margin and -25.5% net margin. Revenue growth is stalled, suggesting poor absorption of costs and limited near-term momentum.
What is AEHR's revenue and growth?
Aehr Test Systems reported revenue of $20.9M.
Does AEHR pay dividends?
Aehr Test Systems does not currently pay dividends.
Where can I find AEHR SEC filings?
Official SEC filings for Aehr Test Systems (CIK: 0001040470) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AEHR's EPS?
Aehr Test Systems has a diluted EPS of $-0.18.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AEHR a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Aehr Test Systems has a SELL rating with 82% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is AEHR stock overvalued or undervalued?
Valuation metrics for AEHR: ROE of -4.1% (sector avg: 10%), net margin of -25.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy AEHR stock in 2026?
Our dual AI analysis gives Aehr Test Systems a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AEHR's free cash flow?
Aehr Test Systems's operating cash flow is $-1.5M, with capital expenditures of $1.9M. FCF margin is -15.9%.
How does AEHR compare to other Utilities stocks?
Vs Utilities sector averages: Net margin -25.5% (avg: 12%), ROE -4.1% (avg: 10%), current ratio 10.62 (avg: 0.8).